UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...

Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.